Business Context and Reporting Period
This Form 8-K was filed by iRhythm Technologies, Inc. on August 7, 2023. The report details the grant of performance-based restricted stock unit awards (PSUs) to the Company's executive leadership team, including the CEO, CFO, and other key officers, effective as of the grant date.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms and equity award structures.
Material Changes
The primary material event reported is the approval and grant of new performance-based equity awards to executives. These awards are contingent upon the achievement of specific operational goals and relative total stockholder return (TSR) over a three-year performance period from July 1, 2023, to June 30, 2026.
Guidance, Outlook, and Management Commentary
- Strategic Objectives: The Board aims to align management with long-term operational objectives to create leadership stability, retain critical talent, and drive the transformation and scaling of the business model.
- Performance Goals: The PSUs are 100% performance-based, weighted equally across three operational goals:
- Enhancing patient experience while significantly increasing patient registrations.
- Achieving specific adjusted EBITDA as a percentage of revenue targets.
- Accelerating new product innovations.
- TSR Adjustment: Earned PSUs are subject to adjustment based on the Company's relative TSR compared to the S&P Healthcare Equipment Select Industry Index. Performance above the 75th percentile increases awards by 25%, while performance below the 33rd percentile decreases them by 25%, subject to caps.
- Award Caps: Maximum achievement is capped at 150% of the target level. If all three operational goals are met, the award reaches the maximum cap regardless of TSR performance.
- Change in Control: In the event of a change in control, operational goals are deemed achieved at the greater of actual or target achievement (two goals), with subsequent vesting subject to time-based schedules or acceleration upon termination without cause.
Important Facts for Investor Verification
- Executive Exposure: The CEO (Quentin Blackford) has a target award of 48,534 shares, while the CFO, CBLO, CCO, and CMO each have a target of 13,589 shares.
- Vesting Conditions: Executives must remain employed through the later of the determination date or August 7, 2026, to vest in the awards.
- Goal Rigidity: There is no interpolation for partial achievement of operational goals; targets must be met to count toward the "target" or "maximum" levels.
- Plan Authority: Awards were granted under the Company's 2016 Equity Incentive Plan.